RecruitingPhase 3NCT06950385
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Studying Familial adenomatous polyposis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rapamycin Holdings Inc.
- Principal Investigator
- Gary Shangold, MD, D.M.DBiodexa
- Intervention
- eRapa (encapsulated rapamycin)(drug)
- Enrollment
- 168 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2031
Study locations (26)
- City of Hope, Arcadia, California, United States
- Yale Cancer Center, New Haven, Connecticut, United States
- Georgetown University, Washington D.C., District of Columbia, United States
- Digestive & Liver Center of Florida, Orlando, Florida, United States
- Cleveland Clinic Florida, Weston, Florida, United States
- University of Chicago, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Department of Surgery, Section of Colon Rectal and Surgery, St Louis, Missouri, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Ohio State University, Columbus, Ohio, United States
- Geisinger Medical Center, Danville, Pennsylvania, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- +11 more locations on ClinicalTrials.gov
Collaborators
Biodexa Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06950385 on ClinicalTrials.govOther trials for Familial adenomatous polyposis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06641310Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)University of Michigan Rogel Cancer Center
- RECRUITINGPHASE1NCT05630794Testing for Safety and Colorectal Cancer Preventive Effects of ONC201National Cancer Institute (NCI)
- RECRUITINGNANCT06538402Ten Versus Fifteen Centimeter Pouch in IPAA SurgeryOdense University Hospital
- RECRUITINGNCT06614738Microbial and Environmental Factors Associated with Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)Hospices Civils de Lyon
- RECRUITINGNANCT06578637Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous PolyposisAbramson Cancer Center at Penn Medicine
- RECRUITINGPHASE3NCT06545526Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous PolyposisYonsei University
- ACTIVE NOT RECRUITINGNCT07461246Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- ENROLLING BY INVITATIONNANCT06649825Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.Shanghai Zhongshan Hospital